| scholarly article | Q13442814 |
| P50 | author | Dawn Coletta | Q42651007 |
| Ralph A. DeFronzo | Q58689309 | ||
| P2093 | author name string | Kohei Kaku | |
| Masafumi Matsuda | |||
| Muhammad A Abdul-Ghani | |||
| Rucha Jani | |||
| Christopher P Jenkinson | |||
| P2860 | cites work | Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 |
| Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes | Q29619192 | ||
| Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. | Q34114554 | ||
| Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. | Q34363859 | ||
| The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes | Q34655580 | ||
| The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes | Q35085591 | ||
| Follow-up report on the diagnosis of diabetes mellitus | Q35567871 | ||
| Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy | Q35587803 | ||
| Pathogenesis of type 2 diabetes mellitus | Q35861736 | ||
| Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose | Q36462545 | ||
| Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. | Q39648063 | ||
| What is the best predictor of future type 2 diabetes? | Q40230327 | ||
| Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? | Q40819765 | ||
| Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. | Q41015653 | ||
| Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness | Q42435292 | ||
| A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes | Q42450726 | ||
| Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response | Q42497232 | ||
| The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study | Q43540904 | ||
| Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig | Q43719948 | ||
| Basal insulin gene expression significantly improves conventional insulin therapy in type 1 diabetic rats | Q43833565 | ||
| Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates | Q43867502 | ||
| Effect of acute hyperglycemia on insulin secretion in humans | Q43869350 | ||
| Disturbances in beta-cell function in impaired fasting glycemia. | Q43869387 | ||
| Acute hyperglycemia alters the ability of the normal beta-cell to sense and respond to glucose | Q43908161 | ||
| Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study | Q43959543 | ||
| Brazilian individuals with impaired glucose tolerance are characterized by impaired insulin secretion. | Q44274737 | ||
| Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance | Q44524591 | ||
| Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study | Q44686996 | ||
| Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose | Q44909462 | ||
| Loss of beta cell function as fasting glucose increases in the non-diabetic range | Q44975445 | ||
| Who are more insulin resistant, people with IFG or people with IGT? | Q45009723 | ||
| beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis | Q45105931 | ||
| ISEC: a program to calculate insulin secretion. | Q50995974 | ||
| The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. | Q51554484 | ||
| Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. | Q51560180 | ||
| Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. | Q51561183 | ||
| The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. | Q51567520 | ||
| Insulin secretion and clearance during low-dose graded glucose infusion. | Q51591764 | ||
| Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. | Q51621447 | ||
| The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. | Q51639006 | ||
| Inverse relationship of metabolic clearance rate of insulin to body mass index | Q68937985 | ||
| Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects | Q71464238 | ||
| Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance | Q77354559 | ||
| P433 | issue | 2 | |
| P921 | main subject | hyperglycemia | Q271993 |
| P304 | page(s) | E401-6 | |
| P577 | publication date | 2008-05-20 | |
| P1433 | published in | American Journal of Physiology - Endocrinology and Metabolism | Q15765671 |
| P1476 | title | The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance | |
| P478 | volume | 295 |
| Q37697697 | A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations |
| Q34684209 | A lower-carbohydrate, higher-fat diet reduces abdominal and intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes |
| Q58598031 | Apolipoprotein B is not superior to non-high-density lipoprotein cholesterol for dyslipidemic classification of glycated hemoglobin-defined diabetic patients |
| Q51367547 | Association of β-cell function and insulin sensitivity with fasting and 2-h plasma glucose in a large Chinese population. |
| Q28546703 | Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes |
| Q37163530 | Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men |
| Q33627460 | Comparing glucose and hemoglobin A1c diagnostic tests among a high metabolic risk Hispanic population |
| Q35578244 | Dapagliflozin lowers plasma glucose concentration and improves β-cell function |
| Q35696511 | Distinct β-cell defects in impaired fasting glucose and impaired glucose tolerance |
| Q37028714 | EFFECT OF HIGH-DOSE VITAMIN D REPLETION ON GLYCEMIC CONTROL IN AFRICAN-AMERICAN MALES WITH PREDIABETES AND HYPOVITAMINOSIS D. |
| Q33969569 | Early insulin secretory dysfunction in korean prediabetic subjects: should we change the criteria for "prediabetes?". |
| Q36716030 | Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM Males |
| Q48505771 | Evaluation of the longitudinal deformation of the left ventricular myocardium in subjects with impaired fasting glucose with and without increased glycated hemoglobin. |
| Q35121539 | Failing beta-cell adaptation in South Asian families with a high risk of type 2 diabetes |
| Q37067110 | Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study |
| Q33952149 | Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS. |
| Q40140158 | Hemoglobin A1c as a marker for identifying diabetes and cardiovascular risk factors: the China Health and Nutrition Survey 2009. |
| Q47360675 | Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans |
| Q33942381 | Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity |
| Q48041211 | Islet amyloid polypeptide response to maximal hyperglycemia and arginine is altered in impaired glucose tolerance and type 2 diabetes mellitus |
| Q33683685 | Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose |
| Q21133002 | Non-cholesterol sterol levels predict hyperglycemia and conversion to type 2 diabetes in Finnish men |
| Q43463113 | One-Hour Postload Plasma Glucose Levels, a Predictor of Additional Risk for Diabetes: Prevalence, Mechanisms, and Associated Cardiovascular and Metabolic Risk Factors in Hispanics |
| Q36426675 | Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance |
| Q37505516 | Pathophysiology of prediabetes |
| Q33610774 | Plasma glucose concentration and prediction of future risk of type 2 diabetes |
| Q37777010 | Prediabetes: The Importance of Early Identification and Intervention |
| Q92151564 | Seasonality, temperature and pregnancy oral glucose tolerance test results in Australia |
| Q83532323 | TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial |
| Q37782506 | Targeting β-Cell Function Early in the Course of Therapy for Type 2 Diabetes Mellitus |
| Q28540239 | The relationship between BMI and glycated albumin to glycated hemoglobin (GA/A1c) ratio according to glucose tolerance status |
| Q34718244 | The relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study. |
| Q26783350 | Treatment of prediabetes |
| Q38241464 | What are the pharmacotherapy options for treating prediabetes? |
| Q34393402 | β-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes. |
Search more.